Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 543.9098 ↓ -1.22%
[as on 23 January, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option -4.49% -1.22% -2.9% -4.96% -5.59% -1.53% 20.82% 15.16% 19.12% 14.52%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.67% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.33%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology12.67%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.07%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology7.26%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology6.29%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.97%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology5.62%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services3.42%
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing3.32%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology3.05%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology2.87%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology2.83%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology2.81%
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services2.59%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.39%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology2.32%
Dr. Lal Path Labs LimitedLALPATHLAB (INE600L01024)Healthcare Services2.29%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology2.16%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.14%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology2.10%
JB Chemicals & Pharmaceuticals LimitedJBCHEPHARM (INE572A01036)Pharmaceuticals & Biotechnology2.01%
Pfizer LimitedPFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.99%
Narayana Hrudayalaya LimitedNH (INE410P01011)Healthcare Services1.95%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology1.50%
Suraksha Diagnostic LimitedSURAKSHA (INE877V01027)Healthcare Services1.48%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services1.35%
Sanofi India LimitedSANOFI (INE058A01010)Pharmaceuticals & Biotechnology1.32%
Sanofi Consumer Healthcare India LimitedSANOFICONR (INE0UOS01011)Pharmaceuticals & Biotechnology1.24%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services1.23%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services1.00%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology0.90%
Akums Drugs and Pharmaceuticals LimitedAKUMS (INE09XN01023)Pharmaceuticals & Biotechnology0.84%
Emcure Pharmaceuticals LimitedEMCURE (INE168P01015)Pharmaceuticals & Biotechnology0.74%
AstraZeneca Pharma India LimitedASTRAZEN (INE203A01020)Pharmaceuticals & Biotechnology0.72%
Indoco Remedies LimitedINDOCO (INE873D01024)Pharmaceuticals & Biotechnology0.61%
Orchid Pharma LimitedORCHPHARMA (INE191A01027)Pharmaceuticals & Biotechnology0.43%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology0.19%
Portfolio data is as on date 31 October, 2025

NAV (Net asset value) history

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - 30 days NAV history

DateNAV
23 January, 2026543.9098
22 January, 2026550.6493
21 January, 2026544.7383
20 January, 2026546.5968
19 January, 2026556.0414
16 January, 2026560.1734
14 January, 2026566.4457
13 January, 2026568.1619
12 January, 2026568.6731
9 January, 2026570.5985
8 January, 2026574.5657
7 January, 2026582.5272
6 January, 2026580.1143
5 January, 2026572.6209
2 January, 2026572.9644
1 January, 2026569.5079
31 December, 2025569.8166
30 December, 2025564.7617
29 December, 2025566.3052
26 December, 2025569.3917
24 December, 2025570.8251
23 December, 2025572.2988
22 December, 2025573.9593
19 December, 2025570.3653
18 December, 2025565.8971
17 December, 2025566.8608
16 December, 2025568.8159
15 December, 2025571.2973
12 December, 2025573.0611
11 December, 2025572.5549

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The latest NAV of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option is 543.9098 as on 23 January, 2026.
  • What are YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are -4.49% as on 23 January, 2026.
  • What are 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are -1.53% as on 23 January, 2026.
  • What are 3 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 3 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 20.82% as on 23 January, 2026.
  • What are 5 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 5 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 15.16% as on 23 January, 2026.
  • What are 10 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 10 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 15.16% as on 23 January, 2026.